Stay updated with breaking news from Nasdaq akya. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Akoya Biosciences (NASDAQ:AKYA – Free Report) had its price objective trimmed by UBS Group from $12.00 to $7.00 in a report issued on Thursday morning, Benzinga reports. The firm currently has a buy rating on the stock. AKYA has been the topic of several other reports. BTIG Research reduced their price objective on Akoya Biosciences […] ....
Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) was the recipient of a large increase in short interest in the month of September. As of September 30th, there was short interest totalling 949,100 shares, an increase of 24.2% from the September 15th total of 764,200 shares. Based on an average daily volume of 156,100 shares, […] ....
Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) was the target of a significant increase in short interest in September. As of September 15th, there was short interest totalling 764,200 shares, an increase of 14.4% from the August 31st total of 668,100 shares. Based on an average daily trading volume, of 154,900 shares, the days-to-cover […] ....